Specify a stock or a cryptocurrency in the search bar to get a summary
United Laboratories International Holdings Ltd
3933The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin products, nervous system drugs, vitamins, veterinary drugs, and vacant gelatin capsules. It also provides intermediate products, such as 6-aminopenicillanic acid, tert-octylammonium clavulanate, anhydrous sodium carbonate sterile, and penicillin G potassium first crystal. In addition, the company manufactures and sells soft capsules casings; holds trademarks; and trades in pharmaceutical products, as well as offers management services. It has operations in the People's Republic of China, India, Europe, the Middle East, South America, rest of Asian regions, and internationally. The company was founded in 1990 and is headquartered in Yuen Long, Hong Kong. Address: 6 Fuk Wang Street, Yuen Long, Hong Kong
Analytics
WallStreet Target Price
90.93 HKDP/E ratio
5.8613Dividend Yield
7.47 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 3933
Dividend Analytics 3933
Dividend growth over 5 years
363 %Continuous growth
5 yearsPayout Ratio 5 years average
20 %Dividend History 3933
Stock Valuation 3933
Financials 3933
Results | 2019 | Dynamics |